Chlorhexidine Gluconate + Climbazole + Phytosphingosine Salicyloyl
209 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
209
Total Reports
3
Deaths Reported
140.0%
Death Rate
Active Ingredients
Chlorhexidine GluconateClimbazolePhytosphingosine Salicyloyl
Administration Routes
TopicalOphthalmicOralUnknown
Species Affected
Dog 174
Cat 23
Human 12
Most Affected Breeds
Crossbred Canine/dog 29
Mixed (Dog) 16
Unknown 13
Shih Tzu 12
Cat (unknown) 10
Bulldog 8
Retriever - Golden 8
Retriever - Labrador 7
Terrier - Yorkshire 7
Dog (unknown) 7
Most Reported Reactions
Application site erythema 59
Application site pruritus 24
Application site irritation 14
Application site reddening 13
Application site hair coat discolouration 7
Vomiting 7
Application site dermatitis 7
Application site pain 6
Application site inflammation 6
Pruritus 6
Lethargy (see also Central nervous system depression in 'Neurological') 6
Hives (see also 'Skin') 5
Outcome Breakdown
Recovered/Normal
103 (49.3%)
Ongoing
80 (38.3%)
Outcome Unknown
22 (10.5%)
Died
2 (1.0%)
Euthanized
1 (0.5%)
Recovered with Sequela
1 (0.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.